December, 06th | 10:19 - 10:23 Faricimab: Hard Exudates in Yosemite/Rhine Diabetic Macular Edema (DME) Clinical Trials RACHITSKAYA ALEKSANDRA Add to calendar
0
December, 06th | 10:23 - 10:27 Real-World effectiveness of Faricimab in patients: 12-Month outcomes from the FARETINA Study LENG THEODORE Add to calendar
December, 06th | 10:31 - 10:35 Outcomes With Aflibercept 8 mg and 2 mg for DME By Baseline BCVA 20/50 or Worse or 20/40 or Better in the PHOTON Trial FERRONE PHILIP Add to calendar
0
December, 06th | 10:35 - 10:39 IOP and Glaucoma-related Outcomes With Aflibercept 8 mg and 2 mg in Patients With DME Through Week 96 in PHOTON KOROBELNIK JEAN-FRANÇOIS Add to calendar
0
December, 06th | 10:39 - 10:43 Impact of residual fluid on visual outcomes in diabetic macular edema SADDA SRINIVAS Add to calendar
0
December, 06th | 10:43 - 10:47 Update on Aflibercept 8mg for Diabetic Macular Edema: The PHOTON Study DO DIANA V. Add to calendar
0
December, 06th | 10:47 - 11:00 Debate: durability, multitarget approach, or synergic effect of different treatments? Add to calendar